Home | Jobs | Contact Us

                                   

2001 Archived News

  • Living Long and Well With Diabetes - Joslin's Award Program  :  [December, 2001] — For people diagnosed with type 1 diabetes, especially early in life, the prospect of living a long and healthy life may seem unattainable or unlikely. In recognition of the unique achievement of successfully managing type 1 diabetes on a long-term basis, Joslin Diabetes Center's Award Program recognizes those special patients who reach milestones of 25 years, 50 years, and 75 years of continuously managing their insulin-dependent diabetes.
  • Cloning Research and Diabetes  :  [November 28, 2001] — Cloning and stem cell research has become a controversial topic again this week in the wake of an announcement by Worcester-based Advance Cell Technology that they have successfully cloned a human embryo, en route to developing another possible resource of embryonic stem cells that could develop into transplantable tissues. A Joslin researcher discusses how this research may or may not help people with diabetes.
  • Looking for Those with "Borderline Diabetes"  :  [November 6, 2001] — Now that nationwide clinical research demonstrates that the risk of type 2 diabetes can be cut by more than 50 percent by changes in diet and exercise, it's more important than ever that people with "borderline diabetes" be identified — and receive the training they need to prevent the disease.
  • Stepped-up Airport Security and its Effects on Travelers with Diabetes  :  [October 22, 2001] — The Federal Aviation Administration (FAA) has implemented stepped-up security measures at the nation's airports in response to the tragic events of September 11. Some of the new security measures affect airline passengers with diabetes.
  • Joslin Staff Receive Awards  :  [September, 2001] — Two Joslin staff members in the section on Behavioral and Mental Health recently received awards for their contributions to diabetes education, patient care, and research.
  • Age-old Drug Points To Potential New Treatments for Type 2 Diabetes  :  [August 30, 2001] — The age-old drug aspirin may point to a brand new way to treat type 2 diabetes, according to scientists at Joslin Diabetes Center and the University of California in San Diego.
  • Why is Obesity A Growing Problem In America?  :  [August 10, 2001] — Over 100 million Americans are estimated to be overweight.  Since being even 10 or 20 pounds overweight can trigger type 2 diabetes, it’s no wonder scientists are concerned about Americans’ expanding waistlines.  What is the link between diabetes and obesity? What can be done to reverse the alarming trend? Joslin’s new chief of obesity research shares her views.
  • Joslin President's Views on New Stem Cell Developments  :  [August 10, 2001] — Joslin President C. Ronald Kahn, M.D. believes President Bush's decision on stem cell research is a good first step. But Congress can do more to ensure the future of this promising area of research.
  • Diet, Exercise Dramatically Decrease Diabetes Risk  :  [August, 2001] — A major new study conducted at Joslin and 26 other sites nationwide reports that people at high risk for developing type 2 diabetes can lower their chances of getting the disease by as much as 58 percent. How? Through modest, sustained weight loss – 10 to15 pounds – and about 30 minutes of moderate exercise (such as brisk walking) each day.
  • We Can Delay Type 2 Diabetes—Now What?  :  [August, 2001] — If you have type 2 diabetes, others in your family are at risk. Here's information to share with them, and with anyone else you know who has a family history of the disease, is overweight, over 40, doesnít exercise much, and/or comes from an ethnic group at high risk for diabetes, such as African Americans, Native Americans, Hispanic or Asian Americans.
  • Stem Cell Research and Diabetes  :  [July, 2001] — Joslin President C. Ronald Kahn M.D., presents his views on the ongoing debate over federal funding of embryonic stem cell research.
  • Insulin Injections Fail To Prevent Type 1 Diabetes; Separate Prevention Trial Tests Benefit of Oral Insulin  :  [June 23, 2001] — Low-dose insulin injections do not delay or prevent type 1 diabetes in people who have a high risk (50 percent or greater) of developing the disease within 5 years, researchers announced at the annual meeting of the American Diabetes Association. The finding emerged from a recently completed clinical trial that answers a question researchers have asked for years: Can insulin injections stop or slow the development of type 1 diabetes in people at high risk?
  • Research in Mice Suggests Possible New Diabetes Treatment  :  [June, 2001] —A study in mice reported in this month's Journal of Clinical Investigation suggests that a two-part treatment may re-train the immune system to stop attacking islet cells, and then encourage remaining islet cells to multiply. If confirmed by other research and in human studies, this could lead to a potentially novel treatment for patients with newly diagnosed diabetes at or near the time they develop the disease.
  • Diabetes Stamp Dedication Ceremony  :  [March, 2001] —Over 400 people jammed Joslin Diabetes Center in Boston on Friday, March 16th for the first day of issue ceremony for the Diabetes Awareness Stamp from the U.S. Postal Service.
  • New Study Seeks Genetic Link to Type 1 Diabetes  :  [February, 2001] — A new research study at Joslin is looking for people with type 1 diabetes between the ages of 5-40 who either have immediate relatives with type 1 diabetes or who themselves have another autoimmune disease such as multiple sclerosis or Addison's disease. The purpose of the study is to to see if the gene or genes that make someone more likely to develop type 1 diabetes can be identified.
  • Two Joslin Research Studies Among Top Advances in 2000  :  [January, 2001] — Two Joslin research studies have been named by leading national science and health magazines as among the top research advances of the year 2000.
 
Privacy | Disclaimer | Site Map | Back to Top